Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier, and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis, and many other conditions. We are committed to providing answers that matter – through medicines and information – for some of the world's most urgent medical needs.

Lilly employs more than 38,000 people worldwide and markets our medicines in 125 countries. We also have major research and development facilities in eight countries and conduct clinical trials in more than 50 countries.

Founded in 1966, Lilly Taiwan is dedicated to providing best-in-class products and exceptional service to our customers in Taiwan. In the future, we will work on reinforcing our relationships with the local government, medical societies, and advocacy groups in the hope of contributing more to Taiwan’s life sciences industry. At the same time, we will conduct more and more philanthropic activities because we believe that we have a responsibility to be a good corporate citizen in our communities.